GFAP and early-onset autosomal dominant Alzheimer disease: Peretti et al. show that a circulatory marker of neuroinflammation—glial fibrillary acidic protein—is associated with tau pathology in lateral temporal and frontal regions in patients with Alzheimer's disease, independent of amyloid load.